Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001079822 | SCV000166511 | benign | Microcephaly, normal intelligence and immunodeficiency | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000121612 | SCV000170640 | benign | not specified | 2014-01-25 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000128985 | SCV000172874 | benign | Hereditary cancer-predisposing syndrome | 2014-11-28 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV000121612 | SCV000309098 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Genetic Services Laboratory, |
RCV000121612 | SCV000595908 | benign | not specified | 2018-01-19 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000759168 | SCV000604436 | benign | not provided | 2023-06-19 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000121612 | SCV000888325 | benign | not specified | 2022-05-03 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001079822 | SCV001327035 | benign | Microcephaly, normal intelligence and immunodeficiency | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign. |
National Health Laboratory Service, |
RCV002225382 | SCV002505286 | benign | Hereditary breast ovarian cancer syndrome | 2022-04-19 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000128985 | SCV002536605 | benign | Hereditary cancer-predisposing syndrome | 2020-11-04 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002498571 | SCV002795433 | likely benign | Microcephaly, normal intelligence and immunodeficiency; Aplastic anemia; Acute lymphoid leukemia | 2022-04-19 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003315761 | SCV004016055 | benign | Acute lymphoid leukemia | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000759168 | SCV004184738 | benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | NBN: BP4, BS1, BS2 |
ITMI | RCV000121612 | SCV000085810 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
True Health Diagnostics | RCV000128985 | SCV000788076 | likely benign | Hereditary cancer-predisposing syndrome | 2017-08-17 | no assertion criteria provided | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001354750 | SCV001549441 | benign | Malignant tumor of breast | no assertion criteria provided | clinical testing | The NBN p.Thr497Ala variant was identified in 6 of 2520 proband chromosomes (frequency: 0.002) from American individuals or families with a history of Lynch syndrome associated cancers and/or polyps (Yurgelun 2015). The variant was also identified in dbSNP (ID: rs3026268) “With other allele”, ClinVar (classified benign by Invitae, GeneDx, Ambry Genetics, Prevention Genetics, ARUP Laboratories and likely benign by Genetic Services Laboratory (University of Chicago) and Quest Diagnostics Nichols Institute San Juan Capistrano), Zhejiang Colon Cancer Database (1X) and in control databases in 622 (10 homozygous) of 276618 chromosomes at a frequency of 0.002 increasing the likelihood this could be a low frequency variant (Genome Aggregation Database Feb 27, 2017). Breakdown of the observations by population include African in 569 (10 homozygous) of 24014 chromosomes (freq: 0.02), Other in 4 of 6450 chromosomes (freq: 0.0006), Latino in 39 of 34386 chromosomes (freq: 0.001), European Non-Finnish in 7 of 126274 chromosomes (freq: 0.00006), and South Asian in 3 of 30770 chromosomes (freq: 0.0001); while the variant was not observed in the Ashkenazi Jewish, East Asian, and European Finnish populations.. The variant was not identified in Clinvitae, Cosmic, and LOVD 3.0 databases. The p.Thr497 residue is conserved in in mammals but not in more distantly related organisms however computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information this variant meets our laboratory's criteria to be classified as benign. | |
Institute for Biomarker Research, |
RCV000128985 | SCV002050311 | benign | Hereditary cancer-predisposing syndrome | 2021-11-09 | no assertion criteria provided | clinical testing |